Absci (ABSI) Change in Account Payables (2020 - 2026)

Absci's (ABSI) quarterly Change in Account Payables came in at -$2.0 million in Q1 2026, up 6.46% year-on-year from -$1.9 million in Q1 2025, and down 5613.51% quarter-over-quarter from $37000.0 in Q4 2025.

Absci (ABSI) Change in Account Payables (2020 - 2026) Analysis & Trends

Absci has disclosed Change in Account Payables across 7 years of filings, most recently posting -$2.0 million for Q1 2026.

  • Change in Account Payables for Q1 2026 came in at -$2.0 million, up 6.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.2 million (up 305.83% YoY), and the FY2025 annual result was $1.1 million, down 36.8% from the prior year.
  • Change in Account Payables came in at -$2.0 million for Q1 2026 at Absci, down from $37000.0 in the prior quarter.
  • In the past five years, Change in Account Payables ranged from a high of $6.8 million in Q2 2025 to a low of -$3.6 million in Q3 2025.
  • The 5-year median for Change in Account Payables is $22000.0 (2022), against an average of -$31411.8.
  • Peak annual rise in Change in Account Payables reached 16607.32% in 2025, while the deepest fall reached 11940.0% in 2025.
  • Absci's Change in Account Payables stood at $691000.0 in 2022, then sank by 158.76% to -$406000.0 in 2023, then jumped by 486.7% to $1.6 million in 2024, then tumbled by 97.64% to $37000.0 in 2025, then sank by 5613.51% to -$2.0 million in 2026.
  • The last three Change in Account Payables figures came in at -$2.0 million (Q1 2026), $37000.0 (Q4 2025), and -$3.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Payables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -3.26 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 35.60 Mn
9 Abivax 91.96 Bn 91.96 Bn - -9.42 Mn
10 Absci 1.13 Bn 1.01 Bn - -2.04 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.04 Mn
Mar 31, 2026 -2.04 Mn
Dec 31, 2025 37,000.00
Dec 31, 2025 37,000.00
Sep 30, 2025 -3.61 Mn
Sep 30, 2025 -3.61 Mn
Jun 30, 2025 6.85 Mn
Jun 30, 2025 6.85 Mn
Mar 31, 2025 -2.18 Mn
Mar 31, 2025 -2.18 Mn
Dec 31, 2024 1.57 Mn
Dec 31, 2024 1.57 Mn
Sep 30, 2024 -30,000.00
Sep 30, 2024 -30,000.00
Jun 30, 2024 41,000.00
Jun 30, 2024 41,000.00
Mar 31, 2024 150,000.00
Mar 31, 2024 150,000.00
Dec 31, 2023 -406,000.00
Dec 31, 2023 -406,000.00